Life Science / Inhibitors/Agonists / / c-RET

Cat. No. Name/Description Purity
A1719304 Enbezotinib (enantiomer)

98%
A1173510 Pz-1

99%
A1176675 SPP-86

99%
A1329297 Fedratinib hydrochloride hydrate

97%
A1324667 JNJ-38158471

98%
A345883 Fedratinib

98%
A177150 Regorafenib

98%
A1949837 BT44

98%
A1145218 Selpercatinib

98%
A2667069 Selpercatinib

99%
A248926 AST 487

98%
A1275491 RET V804M-IN-1

98+%
A144993 Agerafenib

98%
A395008 Danusertib

99+%
A469558 TG101209

98+%
A723612 GSK3179106

98%
A1374317 RET-IN-3

98+%
A984305 BBT594

98+%
A712840 AD80

99+%
A468588 Pralsetinib

99%

No Data

Name/Description c-RET Other Targets Purity
Regorafenib +++

RET, IC50: 1.5 nM

98%
TG101209 ++

RET, IC50: 17 nM

FLT3 99%+
Danusertib +

RET, IC50: 31 nM

99%+
AD80 ++++

RET wt, IC50: 1.3 nM

RET V804M, IC50: 0.6 nM

Src,Raf 99+%
1. Hovering the mouse over the "+" can display the specific value of the relevant IC50. The more "+", the stronger the inhibitory effect. 2. "✔" Indicates that the compound has inhibitory effects on the corresponding subtypes, but there is currently no relevant data on the intensity of inhibition.